A recent study conducted by precision psychiatry firm NeuroKaire provides significant data regarding the intersection of mental health diagnoses and cannabis consumption patterns across generational cohorts. The findings indicate that self-reported cannabis usage is particularly prevalent among individuals diagnosed with depression, with Gen Z leading the trend. According to the report, 50% of surveyed Gen Z respondents with a depression diagnosis currently consume cannabis.
This usage pattern scales across age groups, with 48% of Millennials, 41% of Gen X, and 22% of Boomers reporting either regular or occasional use. Beyond THC-dominant products, the study highlights a pronounced adoption of CBD among those reporting depression symptoms. Specifically, Gen Z individuals with a depression diagnosis utilize CBD products at a rate 59% higher than their non-depressed counterparts.
This research suggests that cannabis and hemp-derived products are increasingly integrated into the self-care and mental health management routines of a substantial consumer base. For the industry, these metrics provide a data-driven look at how mental health awareness is shifting consumer behaviors and product preferences. As consumers increasingly view cannabis as a functional tool for symptom management, the data suggests that demographics identifying with mental health challenges are demonstrating higher-than-average engagement with dispensary and retail product categories, including both traditional cannabinoids and non-psychoactive wellness products.